Cutaneous drug reactions
- 30 November 2012
- journal article
- case report
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 130 (5), 1225-1225.e6
- https://doi.org/10.1016/j.jaci.2012.08.007
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Exanthematous Drug EruptionsThe New England Journal of Medicine, 2012
- A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity?Journal of the American Academy of Dermatology, 2012
- Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinkingClinical and Experimental Dermatology, 2011
- Drug Allergy: An Updated Practice ParameterAnnals of Allergy, Asthma & Immunology, 2010
- Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrumDermatologic Therapy, 2009
- Fixed drug eruption: pathogenesis and diagnostic testsCurrent Opinion in Allergy and Clinical Immunology, 2009
- Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-StudyJournal of Investigative Dermatology, 2008
- Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)British Journal of Dermatology, 2007
- Dermatologic drug reactionsImmunology and Allergy Clinics of North America, 2004
- Differential Diagnosis of Severe Cutaneous Drug EruptionsAmerican Journal of Clinical Dermatology, 2003